Responsive image

Common name


methyl N-(2,2-dimethylpropyl)carbamate

IUPAC name


methyl N-(2,2-dimethylpropyl)carbamate

SMILES


O(C(=O)NCC(C)(C)C)C

Common name


methyl N-(2,2-dimethylpropyl)carbamate

IUPAC name


methyl N-(2,2-dimethylpropyl)carbamate

SMILES


O(C(=O)NCC(C)(C)C)C

INCHI


InChI=1S/C7H15NO2/c1-7(2,3)5-8-6(9)10-4/h5H2,1-4H3,(H,8,9)

FORMULA


C7H15NO2

Responsive image

Common name


methyl N-(2,2-dimethylpropyl)carbamate

IUPAC name


methyl N-(2,2-dimethylpropyl)carbamate





Molecular weight


145.200

clogP


0.485

clogS


-1.601

Frequency


0.0003





HBond Acceptor


2

HBond Donor


1

Total Polar
Surface Area


38.33

Number of Rings


0

Rotatable Bond


3

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00923 Atazanavir Responsive image Anti-HIV Agents; Protease Inhibitors; HIV Protease Inhibitors; Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2wkz_ligand_2_77.mol2 2wkz 1 -6.64 C(NC(=O)OC)C(C)(C)C 10
2cen_ligand_2_63.mol2 2cen 1 -6.63 C(C(C)(C)C)NC(=O)OC 10
2uy0_ligand_2_39.mol2 2uy0 1 -6.63 N(C(=O)OC)CC(C)(C)C 10
2wl0_ligand_2_77.mol2 2wl0 1 -6.63 C(C(C)(C)C)NC(=O)OC 10
2cej_ligand_2_37.mol2 2cej 1 -6.61 O=C(NCC(C)(C)C)OC 10
2cem_ligand_2_63.mol2 2cem 1 -6.60 C(C(C)(C)C)NC(=O)OC 10
2uxz_ligand_2_69.mol2 2uxz 1 -6.59 C(C)(C)(C)CNC(=O)OC 10
2xye_ligand_2_114.mol2 2xye 1 -6.58 N(C(=O)OC)CC(C)(C)C 10
2xyf_ligand_2_117.mol2 2xyf 1 -6.55 O(C(=O)NCC(C)(C)C)C 10
194 , 20